OpenAI, the creator of ChatGPT, has released a new report that offers a glimpse into how Americans are using the company's large language models models. It might not be quite what investors would expect. According to the AI giant, around "10% of the world's adult population" has adopted its consumer chatbot since its Nov. 2022 launch. Usage has also become much more representative of the U.S. population after originally skewing male. The 'mainstreaming' of the AI chatbot has seen rapid growth in non-work ...

Neither the U.S. central bank’s decision to drop the interest rate nor Federal Reserve Chair Jerome Powell’s measured comments following the announcement stirred Bitcoin much on Wednesday. But analysts whom Decrypt spoke to are largely upbeat that the asset's price would gain ground throughout the remainder of the year.  Powell’s emphasis on a sagging employment market and wider concerns will likely result in additional rate cuts, sending Bitcoin and other cryptocurrencies higher, they said. They also noted ...

Core Viewpoint - Sinclair, the largest ABC affiliate group in the U.S., has decided to indefinitely preempt "Jimmy Kimmel Live!" due to inappropriate comments made by Mr. Kimmel regarding the assassination of Charlie Kirk, which they deemed insensitive at a critical moment for the country [1] Company Actions - Sinclair has communicated with ABC about the decision to preempt the show starting tonight [1] - Following discussions, ABC has suspended the production of "Jimmy Kimmel Live!" [1] Statements from Leadership - Vice Chairman Jason expressed that Mr. Kimmel's remarks were inappropriate and deeply insensitive [1]

MarcumAsia Co-Chair Drew Bernstein, left, attended the Asia Go IPO Summit in Hong Kong last week.Marcum Asia Though the Nasdaq is headquartered New York and many of its best-known companies such as Nvidia and Microsoft are based in the U.S., overseas listings by Asian companies account for about half of its IPOs these days. Tougher listing rules proposed by the Nasdaq this month for smaller companies – particularly from China -- would improve protection for investors yet have a “dramatic” impact leads busi ...

Core Insights - Fangzhou Inc. received the "Excellence Award" at Gilead Sciences' 2025 Multi-Channel Conference, recognizing its innovation in AI-driven Internet healthcare solutions [1][2] - The collaboration between Fangzhou and Gilead focuses on enhancing chronic disease management and improving patient outcomes through digital health solutions [3][6] Company Achievements - Fangzhou's AI technology has significantly advanced chronic disease management, as highlighted by Dr. Xie Fangmin during the conference [2][4] - The company serves 52.8 million registered users and 229,000 physicians, positioning itself as a leader in online chronic disease management in China [8] Strategic Collaborations - Fangzhou and Gilead are working together on disease prevention, treatment, and digital chronic care services, aligning their visions for better health outcomes [3][6] - The launch of Gilead's initiative "Together for Health" aims to enhance patient-centric services, with Fangzhou pledging to contribute to this integrated ecosystem [4][6] Future Directions - Fangzhou plans to leverage its AI technology and chronic disease management services while integrating Gilead's expertise in areas such as HIV and oncology to explore new care models [6]

Core Insights - Fangzhou Inc. received the "Excellence Award" at Gilead Sciences' 2025 Multi-Channel Conference, recognizing its achievements in AI-driven Internet healthcare solutions [1][2] - The award highlights Fangzhou's commitment to innovation and digitalization in healthcare, particularly in chronic disease management [2][4] - Fangzhou aims to deepen collaboration with Gilead to combine advanced therapies with digital health expertise for scalable care solutions [2][6] Company Overview - Fangzhou Inc. is China's leading online chronic disease management platform, serving 52.8 million registered users and 229,000 physicians as of June 30, 2025 [8] - The company specializes in tailored medical care and AI-enabled precision medicine solutions [8] Collaboration with Gilead - Fangzhou and Gilead have closely collaborated in disease prevention, treatment, and digital chronic care services, aligning their visions for improved patient outcomes [4][6] - The conference featured the launch of Gilead's initiative "Together for Health," which aims to enhance patient-centric services and strengthen digital-enabled care [5][6] Future Directions - Fangzhou plans to leverage its AI technology and full-cycle chronic disease management services while integrating Gilead's expertise in HIV, viral hepatitis, and oncology [6] - The company is exploring new "AI+ chronic care" models to advance public health [6]

Unlike previous years, this September saw an uptick in the markets. Key economic reports leading up to the much-awaited Fed announcement of its first cut in a year gave major indices several 52-week highs. Today, the markets, which were flat primarily before the decision except for the Dow Jones Industrial Average, quickly reacted to the announcement. The S&P 500 gained immediately after the Fed approved a quarter-point cut in the Federal Funds Rate on Sept. 17, but plunged right after and closed 0.10% l ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Semler Scientific, Inc. regarding violations of federal securities laws, particularly related to undisclosed investigations by the U.S. Department of Justice [4][6]. Group 1: Legal Investigation and Claims - The firm is encouraging investors who suffered losses in Semler Scientific to contact them to discuss their legal options [1][9]. - A federal securities class action has been filed against Semler Scientific, with a deadline of October 28, 2025, for investors to seek the role of lead plaintiff [4][8]. - The complaint alleges that Semler Scientific and its executives made false or misleading statements and failed to disclose a material investigation by the DOJ into violations of the False Claims Act [6][7]. Group 2: Company Financial Impact - Following the disclosure of initial settlement discussions with the DOJ, Semler Scientific's stock fell over 9% on the next trading day [7]. - The annual report filed with the SEC indicated that the company does not believe the amount of loss from potential DOJ actions can be reasonably estimated [7]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its founding in 1995 and has offices in multiple states [5].

Core Insights - The company showcased a new device that can be controlled using small hand movements at its annual conference [1] Group 1 - The device represents a significant advancement in user interface technology, allowing for more intuitive interactions [1]

Group 1 - DBS Group has formed a partnership with U.S. asset manager Franklin Templeton and blockchain firm Ripple [1] - The collaboration aims to provide accredited and institutional investors with trading and lending services [1] - Services will utilize tokenized money market instruments [1]